InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
20%
T+90 mean return
-20.3%
Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Hexter Joshua, Chief Executive Officer. Officer active across 1 company, notably Oramed Pharmaceuticals INC.. Aggregated, 11 disclosures have been logged. Activity tracked since 11 February 2025. The latest transaction was filed on 11 February 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations11 total
45,000 shares0Common StockSEC:0001213900-25-012240:0
194,500 sharesCommon StockSEC:0001213900-25-001165:0
30,000 sharesCommon StockSEC:0001213900-24-095929:0
180,500 sharesCommon StockSEC:0001209191-24-001148:0
27,000 sharesCommon StockSEC:0001209191-23-033142:0
108,000 sharesCommon StockSEC:0001209191-23-024940:0
42,000 sharesCommon StockSEC:0001209191-22-043767:0
21,000 sharesCommon StockSEC:0001213900-22-000807:0
21,000 sharesCommon StockSEC:0001213900-22-000807
33,333 sharesCommon StockSEC:0001213900-21-046410:0
33,333 sharesCommon StockSEC:0001213900-21-046410
11 of 11 declarations
About Hexter Joshua
Joshua Hexter is Chief Operating Officer and Chief Business Officer at ORAMED PHARMACEUTICALS INC. He oversees the company's operations and business strategies, contributing to its success in the pharmaceutical market.
